|
SUCLG2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.36397576461422E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.70629995980221E-10 |
| Normal-vs-Stage2 |
1.304800000268E-07 |
| Normal-vs-Stage3 |
6.24249999470194E-08 |
| Normal-vs-Stage4 |
2.49690000009295E-07 |
| Stage1-vs-Stage2 |
3.753200E-01 |
| Stage1-vs-Stage3 |
1.893620E-01 |
| Stage1-vs-Stage4 |
8.800700E-03 |
| Stage2-vs-Stage3 |
7.957400E-01 |
| Stage2-vs-Stage4 |
1.585370E-01 |
| Stage3-vs-Stage4 |
2.491800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.9144464619435E-12 |
| Normal-vs-AfricanAmerican |
8.51010000246788E-08 |
| Normal-vs-Asian |
1.487620E-01 |
| Caucasian-vs-AfricanAmerican |
7.538600E-01 |
| Caucasian-vs-Asian |
9.959200E-01 |
| AfricanAmerican-vs-Asian |
9.528200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.82764914313793E-12 |
| Normal-vs-Female |
2.45920000030431E-07 |
| Male-vs-Female |
1.630170E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.27249999426482E-09 |
| Normal-vs-Extreme_Weight |
1.8034462812011E-12 |
| Normal-vs-Obese |
1.37779999631604E-08 |
| Normal-vs-Extreme_Obese |
2.984200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.886400E-01 |
| Normal_Weight-vs-Obese |
7.070200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.797800E-01 |
| Extreme_Weight-vs-Obese |
6.373800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.730800E-01 |
| Obese-vs-Extreme_Obese |
3.275200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.52300005518936E-09 |
| Normal-vs-Age(41-60Yrs) |
1.26487709195544E-12 |
| Normal-vs-Age(61-80Yrs) |
3.99910005111082E-09 |
| Normal-vs-Age(81-100Yrs) |
2.940800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.103560E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.041600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.572220E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.145200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.383960E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.251000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.91180404840452E-12 |
| Normal-VS-Type2 PRCC |
9.78700000042743E-07 |
| Normal-VS-KIRP CIMP |
8.17446110801257E-12 |
| Normal-VS-Unclassified PRCC |
4.46659997876964E-09 |
| Type1 PRCC-VS-Type2 PRCC |
3.356800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.964100E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
3.557200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.962760E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.789790E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.874200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.25980004206383E-09 |
| Normal-vs-N1 |
9.38319977272783E-10 |
| Normal-vs-N2 |
4.05310007778326E-10 |
| N0-vs-N1 |
4.221600E-01 |
| N0-vs-N2 |
5.616200E-03 |
| N1-vs-N2 |
3.113600E-01 |
|
|
